#1 Absolute Worst HEART ADVICE Your Doctor Gives You

Ekberg spends a significant portion of the video illustrating how a patient can walk away with reassurance from a doctor because total cholesterol is under 200 and LDL under 130, yet that same patient may have a TG/HDL ratio of 5, Lp(a) of 75, insulin of 14, hs-CRP of 6, homocysteine of 23, 800 small LDL particles (small LDL % of 67%), and a calcium score of 600. He emphasizes that none of these markers show up on a routine lipid panel, so the doctor’s ‘numbers look fine’ is a false positive that breeds complacency. Each marker is tied to a specific optimal range drawn from the literature, and he presents them as a coherent panel that should be evaluated together. He recommends patients take initiative to get these tests, even if it means paying out-of-pocket for a calcium score ($100–150). The overall message is that without assessing these factors, the standard of care fails to identify and address the true drivers of heart disease.

Ekberg challenges the intuition that elevated blood triglycerides must come from eating too much fat. He explains that when mainstream medicine advises cutting dietary fat, patients inevitably increase carbohydrate consumption, which directly raises triglycerides — exactly the opposite of the intended effect. He references clinical observations from physicians who use low-carb diets: ‘nothing will drop your triglycerides faster’ than restricting carbs and increasing natural fats. High triglycerides, he says, are a direct and powerful marker of insulin resistance because the cells, overfed and resistant, refuse to take up fat just as they refuse glucose. This protocol is not about being ketogenic for everyone but about recognizing that standard low-fat high-carb guidance drives the very lipid abnormalities it claims to treat. The diet must also eliminate omega-6-rich seed oils which promote inflammation, and include non-starchy vegetables for gut health.

Ekberg explains that the same enzyme pathway statins target to lower cholesterol also manufactures CoQ10, a required component for cellular energy production. He emphasizes that while muscle side effects are well-known, the silent damage to organs that cannot ‘complain’ is far more concerning. The NNT data for primary prevention — 100 people treated for 5 years to prevent one non-fatal heart attack — raises the question of whether the benefit justifies the widespread energy starvation. Many countries recognize this risk and mandate co-prescription of CoQ10 at substantial doses of 200–300 mg, sometimes higher. In the U.S., however, this almost never happens. He states unequivocally that if you take a statin, you must take CoQ10. He also notes that for secondary prevention (post-heart-attack), the argument for a statin becomes stronger (NNT 25), but still requires CoQ10 and lifestyle modification.

Ekberg contrasts the extreme stability of saturated fat — ‘basically inert,’ impossible to oxidize under physiological conditions — with the rapid rancidity of polyunsaturated seed oils that go bad when left on the counter. He explains that the body cannot synthesize omega-6; therefore, tissue levels directly reflect dietary intake. When people followed advice to replace butter and red meat with vegetable oils, they dramatically increased the amount of easily oxidized fatty acids in their bodies, which amplified oxidative stress and inflammation, the very processes that underpin atherosclerosis. He recommends a mix of monounsaturated (olive oil) and saturated fats (butter, eggs, meat, coconut) for humans because they provide stable energy without the collateral damage of polyunsaturated oils. This protocol is integral to the low-carb higher-fat approach and directly counteracts the inflammatory cascade that causes small dense LDL and endothelial injury.

Ekberg points out that in the 1960s, body fat composition was about 9% linoleic acid (omega-6), and plaques contained mostly saturated fat. By 2008, linoleic acid had risen to 21.5% of body fat — a 136% increase — and modern plaque samples now contain mostly omega-6 fats. This demonstrates that plaque fat is not causal; it’s just whatever fat is circulating when inflammation creates the plaque. The real driver is inflammation from insulin resistance, high-carb diets, and excess omega-6. The correlation between plaque fat type and body fat type is R=0.89, far stronger than the conventional threshold of 0.7 for a strong correlation, leaving virtually no room for the explanation that dietary saturated fat is the villain. Therefore the advice to cut saturated fat and replace it with vegetable oils has actually worsened the problem.

Ekberg emphasizes that statins reduce cholesterol by inhibiting HMG-CoA reductase, the same pathway that produces CoQ10 (ubiquinone), a critical enzyme for mitochondrial ATP production. Because the heart, brain, liver, and kidneys have the highest energy demands, they are disproportionately starved of ATP. While muscles have pain receptors and can ache or weaken, internal organs have no pain receptors in their functional tissue, so the damage accumulates silently. Many countries co-prescribe CoQ10 at 200–300 mg/day (up to 600 mg therapeutic) alongside any statin prescription, but in the United States this often does not happen. For secondary prevention (post-heart-attack), the NNT drops to 25, making a statin’s case stronger, but even then CoQ10 and lifestyle must be addressed. Statins also raise the risk of type 2 diabetes by 10–25%. He is not saying statins are never indicated, but the decision must account for all these factors and be paired with CoQ10.

Ekberg calls the study ‘really, really bad research.’ He points out that despite its name, the data were originally collected from 22 countries. Keys then hand-picked the seven countries whose data best fit his pre-existing hypothesis that saturated fat intake correlated with heart disease. This selective reporting ignored countries like France or others that did not show the pattern. The result was a public health policy that encouraged avoidance of saturated fat and massive increases in vegetable oil consumption, which later data indicate has fueled the epidemic of insulin resistance, inflammation, and heart disease.